全文获取类型
收费全文 | 17811篇 |
免费 | 1260篇 |
国内免费 | 337篇 |
专业分类
耳鼻咽喉 | 129篇 |
儿科学 | 506篇 |
妇产科学 | 333篇 |
基础医学 | 1197篇 |
口腔科学 | 279篇 |
临床医学 | 1933篇 |
内科学 | 4957篇 |
皮肤病学 | 265篇 |
神经病学 | 868篇 |
特种医学 | 858篇 |
外科学 | 1618篇 |
综合类 | 1368篇 |
预防医学 | 1895篇 |
眼科学 | 518篇 |
药学 | 1517篇 |
2篇 | |
中国医学 | 263篇 |
肿瘤学 | 902篇 |
出版年
2024年 | 42篇 |
2023年 | 717篇 |
2022年 | 1148篇 |
2021年 | 1672篇 |
2020年 | 1253篇 |
2019年 | 1466篇 |
2018年 | 1310篇 |
2017年 | 773篇 |
2016年 | 508篇 |
2015年 | 507篇 |
2014年 | 1276篇 |
2013年 | 1041篇 |
2012年 | 670篇 |
2011年 | 794篇 |
2010年 | 632篇 |
2009年 | 611篇 |
2008年 | 683篇 |
2007年 | 634篇 |
2006年 | 448篇 |
2005年 | 412篇 |
2004年 | 321篇 |
2003年 | 282篇 |
2002年 | 223篇 |
2001年 | 158篇 |
2000年 | 151篇 |
1999年 | 138篇 |
1998年 | 122篇 |
1997年 | 115篇 |
1996年 | 120篇 |
1995年 | 110篇 |
1994年 | 91篇 |
1993年 | 89篇 |
1992年 | 101篇 |
1991年 | 75篇 |
1990年 | 85篇 |
1989年 | 77篇 |
1988年 | 75篇 |
1987年 | 43篇 |
1986年 | 52篇 |
1985年 | 68篇 |
1984年 | 62篇 |
1983年 | 36篇 |
1982年 | 41篇 |
1981年 | 37篇 |
1980年 | 35篇 |
1979年 | 29篇 |
1978年 | 18篇 |
1977年 | 23篇 |
1976年 | 12篇 |
1974年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
11.
Whitney S. Brandt Wanpu Yan Jian Zhou Kay See Tan Joseph Montecalvo Bernard J. Park Prasad S. Adusumilli James Huang Matthew J. Bott Valerie W. Rusch Daniela Molena William D. Travis Mark G. Kris Jamie E. Chaft David R. Jones 《The Journal of thoracic and cardiovascular surgery》2019,157(2):743-753.e3
Objective
Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.Methods
Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.Results
In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.Conclusions
Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection. 相似文献12.
13.
14.
《Clinical gastroenterology and hepatology》2022,20(3):e380-e397
- Download : Download high-res image (232KB)
- Download : Download full-size image
15.
《Clinical gastroenterology and hepatology》2022,20(5):1112-1121.e4
- Download : Download high-res image (419KB)
- Download : Download full-size image
16.
17.
18.
19.
《Mayo Clinic proceedings. Mayo Clinic》2022,97(12):2271-2281
ObjectiveTo investigate the association between type 1 diabetes mellitus (T1D) and type 2 diabetes mellitus (T2D) with risk of sudden cardiac arrest (SCA).MethodsIn a prospective community-based study of SCA from February 1, 2002, through November 30, 2019, we ascertained 2771 cases age 18 years of age or older and matched them to 8313 controls based on geography, age, sex, and race/ethnicity. We used logistic regression to evaluate the independent association between diabetes, T1D, T2D, and SCA.ResultsPatients had a mean age of 64.5±15.9 years, were 33.3% female and 23.9% non-White race. Overall, 36.7% (n=1016) of cases and 23.8% (n=1981) of controls had diabetes. Among individuals with diabetes, the proportion of T1D was 6.5% (n=66) among cases and 2.0% among controls (n=40). Diabetes was associated with 1.5-times higher odds of SCA. Compared with those without diabetes, the odds ratio and 95% CI for SCA was 4.36 (95% CI, 2.81 to 6.75; P<.001) in T1D and 1.45 (95% CI, 1.30 to 1.63; P<.001) in T2D after multivariable adjustment. Among those with diabetes, the odds of having SCA were 2.41 times higher in T1D than in T2D (95% CI, 1.53 to 3.80; P<.001). Cases of SCA with T1D were more likely to have an unwitnessed arrest, less likely to receive resuscitation, and less likely to survive compared with those with T2D.ConclusionType 1 diabetes was more strongly associated with SCA compared with T2D and had less favorable outcomes following resuscitation. Diabetes type could influence the approach to risk stratification and prevention of SCA. 相似文献
20.
Kensuke Kudou Hiroshi Saeki Yuichiro Nakashima Shun Sasaki Tomoko Jogo Kosuke Hirose Qingjiang Hu Yasuo Tsuda Koichi Kimura Ryota Nakanishi Nobuhide Kubo Koji Ando Eiji Oki Tetsuo Ikeda Yoshihiko Maehara 《American journal of surgery》2019,217(4):757-763